載入...
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
Blau syndrome (BS) is an autoinflammatory disorder characterized by non-caseating granulomatous dermatitis, arthritis, and uveitis. We present a case of refractory and severe BS that was treated with the Janus kinase inhibitors (JAKINIBS), Tofacitinib (TOFA) and then Baricitinib (BARI). Our aim was...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
SAGE Publishing
2022-04-01
|
叢編: | Therapeutic Advances in Musculoskeletal Disease |
在線閱讀: | https://doi.org/10.1177/1759720X221093211 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|